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Abstract. 
 
Cell spreading and migration associated with 
the expression of the 92-kD gelatinase (matrix metallo-
proteinase 9 or MMP-9) are important mechanisms in-
volved in the repair of the respiratory epithelium. We 
investigated the location of MMP-9 and its potential 
role in migrating human bronchial epithelial cells 
(HBEC). In vivo and in vitro, MMP-9 accumulated in 
migrating HBEC located at the leading edge of a 
wound and MMP-9 expression paralleled cell migration 
speed. MMP-9 accumulated through an actin-depen-
dent pathway in the advancing lamellipodia of migrat-
ing cells and was subsequently found active in the ex-
tracellular matrix (ECM). Lamellipodia became 
anchored through primordial contacts established with 
type IV collagen. MMP-9 became amassed behind col-
lagen IV where there were fewer cell–ECM contacts. 
Both collagen IV and MMP-9 were involved in cell mi-
gration because when cell–collagen IV interaction was 
blocked, cells spread slightly but did not migrate; and 
when MMP-9 activation was prevented, cells remained 
ﬁxed on primordial contacts and did not advance at all. 
These observations suggest that MMP-9 controls the 
migration of repairing HBEC by remodeling the provi-
sional ECM implicated in primordial contacts.
Key words: cell migration • gelatinase • matrix metal-
loproteinase • bronchial epithelium • wound repair
 
T
 
HE
 
 respiratory epithelium is frequently damaged af-
ter exposure to infectious or noninfectious environ-
mental agents. Regardless of the source of injury,
lesions can vary from the loss of surface epithelium imper-
meability, as a result of tight junction impairment, to a
more-or-less complete shedding of epithelial cells: the
basement membrane may be completely denuded or some
clusters of basal cells may remain attached to it (Man and
Hulbert, 1988). After injury, the respiratory epithelium
initiates a wound healing process to restore its barrier in-
tegrity. One important aspect is the rapid reepithelializa-
tion of the denuded area. Immediately after acute inhala-
tion injury or mechanical deepithelialization of the airway
epithelium, the remaining viable epithelial cells at the
edge of the wound dedifferentiate, spread, and migrate
rapidly over the denuded basement membrane to cover
the deepithelialized zone (McDowell et al., 1979; Nikula
et al., 1988; Erjefält et al., 1995). Several studies have
shown that the most important and first event occurring
during the reepithelialization of the denuded airway mu-
cosa is cell migration and not cell proliferation (Wilhelm,
1953; Lane and Gordon, 1974; Keenan et al., 1982). Cell
migration plays an important part in the rapid reconstitu-
tion of a cohesive epithelial structure (Hérard et al., 1996b).
Cell locomotion involves a number of interdependent
processes including: the formation of cell protrusions or
lamellipodia in the direction of movement, retraction of
posterior formations, and establishment and rupture of ad-
hesive contacts between the cell and the extracellular ma-
trix (ECM)
 
1
 
 (Zigmond, 1989; Small et al., 1996). These in-
teractions between the cell membrane and the ECM are
called focal contacts or focal adhesions and link cytoskele-
tal elements to various ECM molecules. In the lamellipo-
dia, cells adhere to ECM through primordial contacts,
which provide actin filament bundles with the first anchor-
age by which they can exert traction on the ECM, thereby
enabling cell migration. Primordial contacts are transient
structures that enable cell protrusions to anchor for a short
period of time and are rapidly remodeled during migra-
tion. Adhesive contacts may be broken by extracellular
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proteolytic enzymes, such as serine proteinases of the plas-
min system or matrix metalloproteinases (MMPs).
Collectively, MMPs are able to degrade all components
of the ECM and they play key roles in normal physiologic
processes involving ECM remodeling, such as wound heal-
ing, angiogenesis, and development. MMPs also partici-
pate in inflammation, tumor invasion, and metastasis
(Chambers and Matrisian, 1997; Woessner, 1998). After
acute and severe injuries of the airway epithelium, the mu-
cosal damage may result in a total desquamation of the
surface epithelial cells leading to a denuded but intact
basement membrane (Nordin et al., 1977). Repairing cells
spread and migrate onto this continuous thin ECM layer
that underlies the respiratory epithelial cell sheet. The
basement membrane is mostly synthesized by the cells that
lie on it and is essentially composed of type IV collagen,
the molecule that gelatinases, an MMP subclass, preferen-
tially degrade. The gelatinases, also called type IV collage-
nases as a result of their activity, include MMP-2 (72-kD
gelatinase) and MMP-9 (92-kD gelatinase). We previously
demonstrated that, unlike MMP-2, MMP-9 is strongly ex-
pressed by repairing the human bronchial epithelial cells
(HBEC) (Buisson et al., 1996a). Those observations sup-
ported the idea that MMP-9 is linked to the reepithelial-
ization process and early repair events (Vu and Werb,
1998), whereas MMP-2 is important during the prolonged
remodeling phase (Ågren, 1994; Stricklin et al., 1994).
MMP-9 has been shown to be involved in the migration
of several cell types, i.e., macrophages, T lymphocytes, and
eosinophils through reconstituted basement membrane
(Pluznik et al., 1992; Leppert et al., 1995; Okada et al.,
1997). Oligodendrocytes use MMP-9 to put forth pro-
cesses along astrocytes (Uhm et al., 1998). MMP-9 is also a
major factor of human polymorphonuclear cell migration
across the basement membrane and elastase contributes to
this process by activating pro-MMP-9 (Delclaux et al.,
1996). Induction of keratinocyte migration by EGF and
hepatocyte growth factor coincides with the induction of
MMP-9 activity (McCawley et al., 1998). We previously
demonstrated that the epithelial cell–produced MMP-9 ac-
tively contributes to the in vitro wound-repair process of
the respiratory epithelium (Buisson et al., 1996a); MMP-9
is upregulated during the wound-repair process and is de-
tected in migrating basal epithelial cells. Nevertheless, as
Vu and Werb (1998) stated, although much has been
learned about MMP-9 involvement in the wound repair of
various tissues (Matsubara et al., 1991; Oikarinen et al.,
1993; Ågren, 1994; Bendeck et al., 1994; Salo et al., 1994),
its in vivo substrate and functions remain unclear.
In the present study, we examined how HBEC migrat-
ing to repair a wound proceed to anchor to the ECM, how
they could pull on these anchorages to advance, and how
MMP-9 could break these cell–ECM contacts. To investi-
gate in more detail the precise role of MMP-9 in migrating
HBEC, we used new videomicroscopy techniques that en-
able cell tracking and quantification of cell migration
speeds. With these techniques, we were able to study the
relationships between migration speeds of individual cells
and their cellular MMP-9 content and the speeds of lamel-
lipodia extension and MMP-9 accumulation in these pro-
trusions. We observed that type IV collagen is an essential
component that contributes to cell migration by providing
 
the first anchorage (primordial contacts) for HBEC to pull
on. Moreover, MMP-9 accumulates just behind collagen
IV, at sites of fewer cell–ECM interactions, and its activity
is necessary for cell movement. Thus, our working hypoth-
esis is that MMP-9 controls the migration of repairing
HBEC by remodeling the provisional ECM involved with
primordial contacts.
 
Materials and Methods
 
Source of Bronchial Tissue
 
Human bronchial tissues from patients undergoing surgery for bronchial
carcinoma were obtained from microscopically normal areas distant from
the tumor. Immediately after excision, the samples were immersed in a
Ham’s F12/DME (1:3, vol/vol) (GIBCO BRL) supplemented with 80
U/ml penicillin, 80 
 
m
 
g/ml streptomycin (GIBCO BRL), and 50 
 
m
 
g/ml gen-
tamicin (Sigma Aldrich Chimie). Specimens were either processed for cell
isolation or for an ex vivo wound repair model. Some tissue samples were
also directly embedded in Tissue-Tek OCT compound (Sakura) and fro-
zen in liquid nitrogen.
 
Cell Culture
 
HBEC were isolated and cultured according to Buisson et al. (1996b) with
some modifications. In brief, the bronchial tissues were digested overnight
at 4
 
8
 
C with 0.1% Pronase E (Sigma Aldrich Chimie) and dissociated cells
were resuspended in Green’s culture medium (Green et al., 1979), consist-
ing of Ham’s F12/DME (1:3, vol/vol) supplemented with 5 
 
m
 
g/ml insulin,
10 ng/ml EGF, 0.5 
 
m
 
g/ml hydrocortisone, 20 
 
m
 
g/ml adenine, 0.1 nM chol-
era toxin, 5 
 
m
 
g/ml transferrin, 1.5 ng/ml triiodothyronine, 80 U/ml penicil-
lin, 80 
 
m
 
g/ml streptomycin, 50 
 
m
 
g/ml gentamicin, and 10% FCS (all from
Sigma Aldrich Chimie except EGF from Boehringer-Mannheim and FCS
from GIBCO BRL). Glass coverslips (20 mm in diameter) were coated
with rat type I collagen and prepared as previously described (Buisson et
al., 1996a), in the presence of 0.25 
 
m
 
g/ml carbodiimide. The dissociated
HBEC were seeded at a density of 1.25 
 
3
 
 10
 
6
 
 cells/cm
 
2
 
 on collagen
I–coated coverslips and cultured at 37
 
8
 
C in a humidified incubator in the
presence of 5% CO
 
2
 
 and 95% air. Confluent primary cultures of HBEC
were generally obtained after 2 d.
 
Wound-Repair Models
 
In Vitro Wound-Repair Model. 
 
Primary cultures of confluent HBEC were
locally injured as previously described (Buisson et al., 1996a) by deposit-
ing a 1-
 
m
 
l drop of 1 M sodium hydroxide at the center of the culture. So-
dium hydroxide was rapidly neutralized with PBS and a circular wound
area of 
 
z
 
30 mm
 
2
 
 resulted from the sodium hydroxide–induced cellular ly-
sis. Evolution of the remaining surface of the wound area was examined
every day with a CCD-WV50 videocamera (Panasonic) connected to a mi-
croscope and the corresponding wound areas were calculated. The wound
area was expressed as wound relative area, corresponding to the ratio of
the denuded surface at a given time to the denuded surface measured im-
mediately after wounding. When the wound had repaired 30–60% of its
initial surface (1–2 d), cultures were either processed for the measurement
of cell migration or fixed for immunofluorescence labeling studies as fol-
lows. Before fixation, HBEC cultures were rapidly washed in PHEM
buffer (60 mM Pipes, 23 mM Hepes, 10 mM EGTA, 1 mM MgCl
 
2
 
, ad-
justed to pH 6.9). Cultures were sequentially fixed for 5 min in 3.7%
paraformaldehyde in PBS, washed in PBS, incubated for 5 min in 0.1 M
glycine in PBS, washed in PBS, permeabilized for 1 min with 0.5% Triton
X-100, rinsed in PBS, and stored at 4
 
8
 
C until used.
 
Ex Vivo Wound-Repair Model.  
 
Freshly collected human bronchial tis-
sue samples, 
 
z
 
10 
 
3
 
 10 mm, were locally injured with a metallic probe (2
mm in diameter) frozen with liquid nitrogen and applied for 10 s to the tis-
sue sample with a calibrated pressure of 33 kPa. Under these conditions,
only cells of the surface epithelium were damaged and desquamated. Af-
ter wound induction, tissue samples were maintained in culture for 1 d in
Green’s culture medium, embedded in Tissue Tek OCT compound, and
frozen in liquid nitrogen.
 
Cell Migration Assay
 
The migration speeds of cells in injured HBEC cultures were determined 
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as previously described (Zahm et al., 1997). After wound induction, cell
nuclei were stained with a fluorescent dye (Hoechst 33258; Molecular
Probes, Inc.) and the wounded culture was placed in a small transparent
culture chamber of an IM35 inverted microscope (Zeiss). The microscope
was equipped with epifluorescence illumination through an excitation fil-
ter at 360 nm and an emission filter at 510 nm and with a low level silicon
intensified target camera (model 4036; Lhesa). A shutter (Lambda 10–2;
Sutter Instrument) was placed in the excitation light path to illuminate
the culture for short periods of time (1 s) and to simultaneously digitize
the fluorescent images. The images were digitized as 512 
 
3
 
 512 pixels
and 8-bit array, using a Sparc-Classic (Sun Microsystems) workstation
equipped with an XVideo card (Parallax Graphics). Cell migration was
quantified using a previously described software (Zahm et al., 1997) with
three main functions: the detection of cell nuclei, the computation of the
trajectories of these nuclei, and the analysis of these trajectories. From
each nucleus trajectory, the computer calculated the cell migration speed.
When analyzing the effect of the cell’s MMP-9 content or the effect of a
reagent (cytochalasin D, cycloheximide, monensin, batimastat [British
Biotech Pharmaceuticals, Ltd.], anti–MMP-9 antibody [6-6B mAb, a gift
from Dr. French, State University of New York at Stony Brook], or anti–
collagen IV antibody [20411; Institut Pasteur]) on HBEC migration, we
always restricted migration assessment to a population of cells located
close to the edge of the wound, i.e., within a distance corresponding to
 
z
 
1–2 cells starting from the edge of the wound. Indeed, we previously ob-
served that cell migration speed progressively decreases as the distance
from the edge of the wound increases (Zahm et al., 1997).
 
Determination of Extracellular Gelatinase Activity 
during Cell Migration Using Immobilized 
 
3
 
H-Gelatin
 
To assay extracellular gelatinase activity associated to cell migration, we
induced the cells to migrate onto 
 
3
 
H-gelatin–containing type I collagen
and we measured the accumulation of radioactivity in the culture medium.
In short, rat type I collagen was denatured for 1 h at 60
 
8
 
C and radiola-
beled with sodium [
 
3
 
H]borohydride (Amersham) to a specific activity of
8 
 
3
 
 10
 
6 
 
cpm/mg as previously described (Starkey et al., 1984). Glass cover-
slips were coated with rat type I collagen containing 10% 
 
3
 
H-gelatin, and
then extensively washed. The radioactivity remaining on glass coverslips
(6,400 
 
6
 
 900 cpm/cm
 
2
 
) was measured after an overnight hydrolysis with 1 M
sodium hydroxide. During cell migration, the radioactivity released in the
culture medium was counted in a 1900 CA liquid scintillation analyzer
(Packard).
 
Preparation of Cell Protein Extracts
 
Two protein extracts were prepared from migrating HBEC: frozen cells
were first extensively washed in water to prepare a cytosolic fraction, and
then cells and ECM were extracted with detergent (0.1% SDS) as follows.
When injured HBEC cultures had repaired 30–60% of the initial surface
of the wound (1–2 d), cell cultures were washed several times with PBS
and frozen. A cloning cylinder (6 mm inner diameter, corresponding to
the initial wound area) (Bellco Glass, Inc.) was placed on migrating cells,
and cells located inside the cylinder were extensively washed with water at
4
 
8
 
C. The aqueous extract was centrifuged (10,000 
 
g
 
 for 10 min at 4
 
8
 
C) and
lyophilized. The cylinder was filled with 200 
 
m
 
l of 0.1% SDS in water and
the liquid was mixed by pipetting several times at 4
 
8
 
C. Cell extraction with
SDS was repeated 10 times. The combined detergent extracts were centri-
fuged (10,000 
 
g 
 
for 10 min at 4
 
8
 
C) and lyophilized. Aqueous and detergent
lyophilized extracts were resolubilized in Laemmli’s sample buffer to
achieve a 20-fold sample concentration and used immediately for gelatin
zymography, performed as previously described (Buisson et al., 1996a).
 
Immunocytochemistry
 
Sections of frozen bronchial tissues were cut (5-
 
m
 
m thick) at
 
2
 
20
 
8
 
C in a
2800 Frigocut cryostat (Cambridge Instruments) and transferred to gela-
tin-coated slides. Tissue sections and HBEC cultures undergoing repair
were immunoreacted with specific antibodies (Ab) using an indirect im-
munofluorescence labeling technique. All incubations were conducted at
room temperature.
A single immunolabeling technique was performed to localize MMP-9
in bronchial tissues and in repairing HBEC cultures. First, nonspecific
binding was blocked for 30 min with 3% BSA in PBS. The samples were
incubated for 60 min with 3 
 
m
 
g/ml mouse anti–human MMP-9 mAb (GE
209; Oncologix) in 1% BSA in PBS (PBS-BSA). After two washes in PBS
for 5 min, and one wash in PBS–BSA for 5 min, the samples were incu-
bated with biotinylated anti–mouse IgG (Amersham) diluted 1:40 in PBS-
BSA, for 60 min, and then incubated with FITC-streptavidin (Amersham)
diluted 1:50 in PBS for 30 min.
Double immunolabelings with the following Abs were performed to si-
multaneously localize: MMP-9 (10 
 
m
 
g/ml rabbit polyclonal Ab; Biogene-
sis) and vinculin (1:200, mouse hVIN-1 mAb, Sigma Aldrich Chimie); type
IV collagen (1:1000, rabbit 20411 polyclonal Ab) and MMP-9 (3 
 
m
 
g/ml
mouse GE 209 mAb) or vinculin; and cellular fibronectin (1.25 
 
m
 
g/ml rab-
bit polyclonal Ab; Sigma Aldrich Chimie) and vinculin. In these experi-
ments, two successive immunofluorescence labeling incubations were per-
formed with intervening washes. Mouse mAbs were detected with 2 
 
m
 
g/ml
digoxigenin-conjugated sheep anti–mouse F(ab
 
9
 
)
 
2
 
 fragments (Boehringer-
Mannheim) in PBS-BSA, and then with 1.3 
 
m
 
g/ml FITC-conjugated sheep
antidigoxigenin Fab fragments (Boehringer-Mannheim) in PBS-BSA.
Rabbit polyclonal Abs were detected with biotinylated anti–rabbit IgG
(Amersham) diluted 1:40 in PBS-BSA and then with Texas red–streptavi-
din conjugate (Amersham) diluted 1:50 in PBS-BSA. As for fibronectin–
vinculin double immunolabeling, rabbit antifibronectin Ab was detected
with digoxigenin-conjugated sheep anti–rabbit F(ab
 
9
 
)
 
2
 
 fragments and
FITC-conjugated sheep antidigoxigenin Fab fragments, whereas mouse
antivinculin mAb was detected with biotinylated anti–mouse IgG and
Texas red–conjugated streptavidin. We verified the absence of cross-reac-
tivity by incubating control cultures with nonimmune IgG instead of the
primary Ab.
After immunolabeling, cultures were counterstained with Harris hema-
toxylin (Diagnostica Merck) and mounted in Citifluor antifading solution
(Agar Scientific). Actin microfilaments were specifically labeled after in-
cubation with 10 
 
m
 
g/ml FITC–phalloidin (Sigma Aldrich Chimie) and
mounted in Citifluor. All fluorescence-labeled preparations were exam-
ined with an Axiophot microscope (Zeiss) using successive epifluores-
cence and Nomarski differential interference illumination. Immunolabel-
ings were also observed with an MRC 600 confocal laser scanning
microscope (Bio-Rad Laboratories).
 
Results
 
MMP-9 Is Present In Vivo and In Vitro in Migrating 
Bronchial Epithelial Cells
 
Immunofluorescent labeling of normal bronchial epithe-
lium detected MMP-9 only in isolated inflammatory cells
present in the bronchial submucosa, crossing the basement
membrane or infiltrating the pseudostratified surface epi-
thelium (Fig. 1, A and B). Most of these cells had the mor-
phology of polymorphonuclear leukocytes. In remodeled
epithelia, MMP-9 was only detected in clusters of flat basal
cells overlying the basement membrane, in areas where
differentiated cells (goblet and ciliated cells) had been ex-
foliated (Fig. 1, C and D). These basal cells were previ-
ously characterized by the presence of cytokeratins 13 and
14 (Brezillon et al., 1995). We also studied the distribution
of MMP-9 in ex vivo epithelia undergoing repair. After in-
ducing a local wound in fresh human bronchial tissues (ex
vivo wound-repair model), cells were removed only from
the surface epithelium, leaving the basement membrane
intact, as demonstrated by the presence of immunoreac-
tive laminin and type IV collagen as a continuous thin
layer in the damaged area (data not shown). After 1 d in
culture, the epithelial cells had migrated to the edge of the
wound to repair it and they appeared as flat cells (Buisson
et al., 1996b; Roger et al., 1999). MMP-9 was detected in
elongated migrating repairing cells, located close to the
edge of the wound (Fig. 1, E and F). When primary and
confluent cultures of HBEC were locally wounded, cells at
the edge of the wound rapidly spread and migrated to
cover the denuded area (Zahm et al., 1991; Buisson et al.,
1996a; Zahm et al., 1997). During the wound-repair pro- 
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cess, MMP-9 was predominantly found in the forefront of
cells migrating into the damaged area (Fig. 1, G and H).
 
Bronchial Epithelial Cells Expressing MMP-9 Migrate 
More Rapidly to Repair a Wound
 
Because we observed that MMP-9 was present in HBEC
only when they migrated to repair a wound (Fig. 1), we hy-
pothesized that MMP-9 expression in migrating HBEC
may influence HBEC migration. We quantified and stud-
ied cell migration speeds as a function of the presence or
absence of MMP-9 in these cells. Labeling the nuclei of
cells primed to migrate by wound induction enables cell
tracking and cell migration speeds to be measured using a
previously described method (Zahm et al., 1997). We re-
ported earlier that cell migration speed continuously and
significantly decreased with the increasing distance from
the edge of the wound (Zahm et al., 1997). Consequently,
we analyzed the relationship between the cellular MMP-9
content and the cell migration speed only for cells located
near the edge of the wound, i.e., in cells located above the
line in Fig. 2 (A–C). Distinguishing between the cells that
were strongly immunoreactive for MMP-9 (MMP-9 posi-
tive cells) and cells that were weakly labeled or had non-
specific labeling (MMP-9 negative cells), we observed that
MMP-9 positive cells migrated 33.7 
 
6
 
 7.7% (
 
n
 
 
 
5 
 
6) more
rapidly than MMP-9 negative cells. In five out of six exper-
iments, the migration speed of MMP-9 positive cells was
significantly higher (
 
P 
 
, 
 
0.05; Fig. 2 D) than that of MMP-9
negative cells.
 
MMP-9 in Migrating HBEC Is Addressed through an 
Actin-dependent Pathway to Cellular Extensions 
Involved in Cell Migration
 
Because we observed that migrating HBEC contain more
MMP-9 than stationary cells, and, moreover, that MMP-9
seems to accumulate at the advancing edge of migrating
cells (Fig. 1 H and Fig. 2 C, arrows), we hypothesized that
MMP-9 in migrating HBEC may be addressed to cellular
extensions involved in cell migration. To investigate this
possibility, we studied the dynamics of HBEC spreading
and migration together with cellular MMP-9 distribution.
During a 20-min period, we observed that cells migrating
 
Figure 1
 
. Immunolocalization of MMP-9 in cryosections of hu-
man bronchial tissue samples and cultures of repairing HBEC.
The localization of MMP-9 was studied by immunofluorescence,
using the GE 209 mAb. (A and B) A normal bronchial epithe-
lium in which MMP-9 was seen in sporadic inflammatory cells (B,
arrows). (C and D) In a remodeled human bronchial epithelium,
MMP-9 was recognized in elongated cells (D, arrows) spread on
the basement membrane. (E and F) In a normal human epithe-
lium, which had been locally wounded and maintained in culture
for 1 d, MMP-9 was observed only in flat epithelial cells (F, ar-
rows) near the edge of the wound (E, arrow). (G and H) In a con-
fluent primary culture of HBEC, which had been locally injured,
MMP-9 was identified 1 d after injury only in cells located at the
edge of the wound. In these cells, MMP-9 was predominantly lo-
cated around the nucleus but had also accumulated at the ex-
tremity of cellular protrusions in the direction of cell migration
(H, arrows). Bars, 100 
 
m
 
m. 
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at the leading edge of a wound did not move forward at a
uniform speed. Indeed, some lamellipodia advanced rap-
idly, whereas other parts of migratory cells did not move
(Fig. 3, A–F). As seen in Fig. 1 H and Fig. 2 C, a strong im-
munoreactivity for MMP-9 was observed in the cytoplasm
of migrating cells, with a predominant intense perinuclear
distribution, suggesting that MMP-9 is located in the ER
and/or the Golgi apparatus (Fig. 3, G and H). It should
also be noted that a thin band of MMP-9 lined the tip of
those lamellipodia that had moved forward the most dur-
ing the 20-min period preceding cell fixation. The lamelli-
podia that had migrated the most also contained more
MMP-9 (Fig. 3, G and H, arrowheads) than those that had
moved more slowly (arrows).
We previously observed that actin, but not tubulin, poly-
merization is essential for the migration of nasal epithelial
cells (Zahm et al., 1991). The first event occurring during
cell migration is the protrusion of lamellipodia resulting
from a dynamic and directional polymerization of actin fil-
aments (Small et al., 1996). Since we observed that MMP-9
is present in most migrating cells (Fig. 2) and accumulates
at the front line of the most rapidly advancing lamellipodia
(Fig. 3), we hypothesized that changes in the cytoskeletal
organization and, more specifically, disorganization of the
actin microfilament network may alter the trafficking of
MMP-9 from its perinuclear pool to the front line of
extending lamellipodia. Indeed, treatment of repairing
HBEC cultures with 2 
 
m
 
M cytochalasin D, an inhibitor of
actin polymerization, rapidly inhibited cell migration (Fig.
4 A) and prevented the accumulation of MMP-9 at the
forefront of extending lamellipodia (Fig. 4, B–E).
 
MMP-9 Is Identified in Lamellipodia of Migrating 
HBEC Close to Cell–ECM Interactions and Is Found 
under Advancing Lamellipodia
 
Cell migration involves interactions between the cell and
the ECM both through weak primordial contacts at the
leading edge of the cell and larger spear tiplike focal con-
tacts distributed in the more central part of the cell (Lee
 
Figure 2
 
. HBEC containing MMP-9 migrate more rapidly to re-
pair a wound. Primary cultures of confluent HBEC were locally
injured with sodium hydroxide. (A) Labeling of cell nuclei with a
DNA fluorescent dye (Hoechst 33258) at the edge of the wound
on day 1 of the wound-repair process. Positions of cell nuclei are
identified by white circles. (B) Trajectories of cell nuclei re-
corded every 10 min and over a 30-min period. Four cells strongly
positive for MMP-9 are indicated (arrowheads) and the four suc-
cessive positions of the nucleus of one of them is shown. (C) Im-
munofluorescent labeling of MMP-9 after fixation of the culture
at the end of the 30-min recording period. Arrowheads indicate
the same intensely labeled cells as in B. MMP-9 also accumulated
at the forefront of the cellular protrusions (arrows). (D) Mean
cell migration speeds 
 
6
 
 SD for six different experiments con-
ducted on primary cultures of HBEC derived from six different
bronchial samples. Experiment 6 reports the mean migration
speeds for the cells located above the line in A–C. For all six
experiments, the black bars in D report the mean migration
speeds 
 
6
 
 SD of cells strongly positive for MMP-9, whereas white
bars correspond to the values of the other cells. The significance
of the differences between the two groups was determined using 
 
t
 
test. Bar, 100 
 
m
 
m. 
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et al., 1993). These structures can be visualized by reflec-
tion interference contrast microscopy or by the identifica-
tion of one of the many cytoplasmic proteins associated
with focal adhesions (Jockusch et al., 1995). We analyzed
the distribution of vinculin, a protein highly concentrated
in focal adhesions and located close to the plasma mem-
brane, as a marker of migrating HBEC–ECM interactions.
Vinculin accumulated at the leading edge of advancing
lamellipodia and was colocalized with type IV collagen
(Fig. 5, A–C), suggesting that the latter is actively brought
to this site and serves as the first anchorage of migrating
cells. When studying the distribution of type IV collagen
along with that of vinculin in a series of confocal optical
sections through migrating HBEC, we observed that type
IV collagen was still present outside the cell in the ECM,
suggesting that type IV collagen is actively secreted onto
the ECM by migrating HBEC (data not shown). Surpris-
ingly, the accumulation of type IV collagen at the fore-
front of cell protrusions coincided with MMP-9 accumula-
tion just behind it (Fig. 5, D–F). When the leading edge of
a migrating cell was a succession of small protrusions, each
protrusion contained MMP-9 in its central part with pri-
mordial/focal contacts located slightly ahead or more in-
tracellularly on each side of it (Fig. 5, G–I, arrowheads). In
a more central part of a migrating cell, where there was no
type IV collagen (Fig. 5, A–C), vinculin was present in fo-
cal contacts (Fig. 5, B, H, and K) and was closely associ-
ated with fibronectin (Fig. 5, J–L, arrowheads). In con-
trast, at the forefront of the cell, where there was no
fibronectin (Fig. 5, J and L, arrows), vinculin accumulated
with type IV collagen (Fig. 5 C, arrowheads).
We more precisely investigated MMP-9 distribution in
migrating HBEC by using the confocal optical mode for
light microscopic immunodetection of MMP-9. At the api-
cal side of migrating cells, MMP-9 was predominantly lo-
calized around the nucleus (Fig. 6 A). In the protrusions of
migrating cells, vinculin accumulated at the advancing
edge (Fig. 6 D), whereas MMP-9 was mainly detected as
patches just behind it. Some MMP-9 was also but infre-
quently seen to be colocalized with vinculin, i.e., in associ-
ation with primordial/focal contacts (Fig. 6 C). The MMP-9
accumulation was intracellular but close to the basal cell
membrane since MMP-9 was observed along with vinculin
in the same optical section of the cell (Fig. 6, C and D).
When looking at a more basal cellular section, we still ob-
served MMP-9 as patches (Fig. 6 E); then, 0.4-
 
m
 
m lower,
MMP-9 took on a diffuse labeling pattern (Fig. 6 G),
whereas vinculin could no longer be detected (Fig. 6, F
and H). Considering that a lamellipodium is 
 
z
 
0.2–0.3 
 
m
 
m
thick (Abercombie et al., 1970), it can be concluded from
these observations that MMP-9, after reaching the extend-
ing lamellipodia, was secreted onto the ECM.
 
Figure 3
 
. MMP-9 within migrating HBEC accumulates at the tip
of extending lamellipodia. 1 d after injuring primary and conflu-
ent cultures of HBEC, a series of phase-contrast images of cells
migrating and extending lamellipodia at the edge of the wound
were taken at 4-min intervals (A–F). In images B–F, the leading
front of the cells from the previous image (4 min earlier) has
been highlighted with a thin white line. Comparison of this line to
the present position of the cells enables the parts of the cells that
have advanced during the 4-min period to be visualized (B–F, ar-
rows). In F, the thick white line indicates the initial position of
the cells shown in A. At the end of the experiment, the cells were
fixed and MMP-9 distribution was assessed by immunofluores-
cence. (G and H) High magnification of MMP-9 distribution in
the areas analyzed for cell movement (F, insets). MMP-9 is de-
tected at the forefront of migrating cells with more intense fluo-
rescence in more rapidly moving lamellipodia (G and H, arrow-
heads) than in those moving more slowly (H, arrows). Bars, 50 
 
m
 
m. 
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Bronchial Epithelial Cell Migration Requires Both the 
Activity of MMP-9 and the Anchorage of Lamellipodia 
onto Type IV Collagen
 
In the advancing lamellipodia of migrating HBEC, type IV
collagen accumulated at the extremity of the lamellipodia,
whereas MMP-9 was mainly located within the lamelli-
podia and behind type IV collagen. This observation sug-
gests that both molecules may be actively involved in the
spreading and/or migration processes. To investigate this
possibility in more detail, we studied the migration of
HBEC in the presence of either the 6-6B mAb, known to
block MMP-9 activation (Ramos-DeSimone et al., 1993)
or a high affinity polyclonal Ab specific to type IV col-
lagen. After exposure to either Ab, the migration speed of
the cells at the edge of the wound progressively declined
(Fig. 7, A and B). After exposure to a control Ab or the
anti–MMP-9 mAb, stress fibers and spotty actin deposits
were seen at the migrating front of the cells (Fig. 7, C and
D). In contrast, in the presence of the anti–collagen IV
Ab, cells spread without notable actin accumulation at
the leading edge of the cell, even though microfilament
bundles were still present in the central part of the cell
(Fig. 7 E).
After sustained exposure of repairing HBEC to the
anti–MMP-9 mAb, only tiny movements of cells at the
edge of the wound could be detected (Fig. 8 D). When ob-
served by phase-contrast microscopy, the leading edge of
these cells appears as a dark and thick border, suggesting
the presence of denser cytoplasmic constituents and/or
stronger interactions with the ECM (Fig. 8 A). On the
other hand, after exposure to the anti–collagen IV Ab, the
cell border was more faint (Fig. 8 E). In the latter situa-
tion, small forward and backward movements of the cell
border were observed (Fig. 8, F–H), suggesting that the
cells made small movements ahead but were not able to go
any further, probably as a consequence of defective cell
anchorage depriving them of their traction system. We can
conclude the following from these experiments: in the
presence of 6-6B anti–MMP-9 mAb, HBEC attach firmly
to type IV collagen but are unable to modify this anchor-
age and, thus, remain stuck to collagen IV; and in the pres-
ence of the anti–collagen IV Ab, HBEC initiate small
 
Figure 4.
 
HBEC migration and MMP-9 trafficking to advancing
lamellipodia were rapidly inhibited by treatment with cytochala-
sin D. (A) 1 d after injuring primary and confluent cultures of
HBEC, cell migration was measured after fluorescent labeling of
their nuclei, as described in Materials and Methods. Migration
speeds of cells (
 
n
 
 
 
5 
 
20) located at the edge of the wound were
measured every 5 min over a 20-min control period. After 20
min, 2 
 
m
 
M cytochalasin D (closed circles) or its vehicle (0.05%
DMSO, open circles) was added to the culture medium and the
migration speeds of the same cells were monitored again over a
30-min period. Each bar represents the mean migration speed 
 
6
 
SD of 20 cells. (B and D) Phase-contrast micrographs and (C and
E) MMP-9 fluorescence immunolabeling of a control culture
fixed 3 min after the addition of 0.05% DMSO (B and C) and of
another culture fixed 3 min after the addition of 2 
 
m
 
M cytochala-
sin D (D and E). MMP-9 can be seen at the tip of advancing
lamellipodia only in the vehicle control experiment (C, arrow-
heads). Bar, 100 
 
m
 
m. 
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spreading movements but are unable to go any further be-
cause no definite contact can be established with the ECM
to form the traction mechanism.
 
HBEC Migration Coincides with an Increased 
Extracellular Gelatinase Activity and an Accumulation 
of Active MMP-9 in the ECM
 
We previously observed that MMP-9 was activated during
the in vitro wound-repair process of the respiratory epi-
thelium (Buisson et al., 1996a). The ability of anti–MMP-9
mAb to block HBEC migration suggests that MMP-9
must be activated for migration to occur. Moreover, we
have observed that MMP-9 is present in the ECM underly-
ing advancing lamellipodia of migrating HBEC (Fig. 6).
Therefore, we hypothesized that the MMP-9 that is depos-
ited on the ECM is active and able to degrade the sur-
rounding ECM. When 
 
3
 
H-gelatin, a substrate for MMP-9,
Figure 5. Immunofluorescence analysis of the cellular distribution of MMP-9 in migrating HBEC. Using immunofluorescent double la-
beling techniques to study repairing HBEC cultures, we evaluated the distribution of the following proteins: (A–C) type IV collagen
(Col IV, polyclonal Ab) and vinculin (Vinc, hVIN-1 mAb); (D–F) type IV collagen and MMP-9 (GE 209 mAb); (G–I) MMP-9 (poly-
clonal Ab) and vinculin; and (J–L) cellular fibronectin (Fn, polyclonal Ab) and vinculin. C, F, I, and L are double exposures taken at ex-
citation frequencies of double-labeled cultures; in these frames, a yellow color indicates the colocalization of red and green fluores-
cence. (A–C) Type IV collagen and vinculin accumulated at the forefront of a migrating cell (C, arrowheads). (D–F) In two advancing
lamellipodia, MMP-9 was amassed behind type IV collagen (F, arrowheads). (G–I) Each cytoplasmic protrusion of a migrating cell is
characterized by central accumulation of MMP-9 surrounded by vinculin at the tip of the protrusions and within the cell (I, arrow-
heads). (J–L) At the basal side and in the central part of a migrating cell, fibronectin accumulates close to vinculin (L, arrowheads) but,
at the forefront of the cell, only vinculin accumulates (L, arrows). Bar, 40 mm. 
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was incorporated into type I collagen on which repairing
HBEC migrate, we observed a progressive release of ra-
dioactivity in the culture medium (Fig. 9, A and B, con-
trol), suggesting a degradation of the ECM by gelatinase.
Interestingly, every experimental condition that decreased
migration of repairing HBEC (cycloheximide, batimastat,
and an absence of growth factors) also decreased the deg-
radation of radioactive ECM (Fig. 9, A and B). 
As we already observed with puromycin (Zahm et al.,
1991), no repair occurred in the presence of cyclohexi-
mide, which is another inhibitor of protein synthesis.
When cycloheximide was tested in a migration assay, we
observed that cycloheximide significantly inhibited cell
migration after an incubation period of 1–2 h, suggesting
that this time is needed to clear the intracellular pool of
proteins, including MMP-9 and type IV collagen, involved
in HBEC migration (data not shown). Monensin, added to
migrating HBEC at a 5-
 
m
 
M concentration, inhibited cell
migration within 10 min (data not shown). These results
suggest that cell migration is closely dependent upon the
production and secretion of proteins. Batimastat, a broad
spectrum MMP inhibitor, known to inhibit invadopodial
degradation of fibronectin by invasive MDA-MB-231
breast cancer cells (Kelly et al., 1998), inhibited in a dose-
dependent way HBEC migration and 
 
3
 
H-gelatin degrada-
tion (Fig. 9, A and B). The inhibition of HBEC migration
that we observed in the different experimental conditions
paralleled the inhibition of 
 
3
 
H-gelatin degradation. These
results suggest that cell migration involves the gelatinase-
dependent degradation of the ECM on which cells mi-
grate. In an aqueous protein extract of migrating HBEC,
MMP-9 is present only in its 92-kD inactive precursor
form (Fig. 9 C, lanes A). After the removal of the cytosol,
a detergent extraction of both membranes of migrating
cells and their associated ECM revealed that MMP-9 is
mainly present in these compartments in its 84-kD active
form (Fig. 9 C, lanes D). This observation suggests that
MMP-9, present at the cell membrane or deposited on the
ECM during cell migration, is active.
 
Discussion
 
Our results clearly demonstrate that MMP-9 is actively in-
volved in the migration of repairing HBEC: MMP-9 is
only detected in migrating HBEC and its expression coin-
cides with the cell migration speed; MMP-9 in migrating
HBEC is addressed to lamellipodia advancing in the direc-
tion of migration and is found active on the ECM; HBEC
migration coincides with an increased extracellular gelati-
nase activity; blocking MMP-9 activation or MMP-9 activ-
ity results in less cell migration; the MMP-9 substrate, type
IV collagen, is present in primordial contacts of migrating
 
Figure 6.
 
Confocal images of MMP-9 and vinculin distributions
in one migratory cell at the edge of the wound in a repairing
HBEC culture. After fixation (day 1 postinjury), the culture was
processed for double immunofluorescence labeling of MMP-9
(polyclonal Ab) and vinculin. Four serial confocal optical sec-
tions (A and B, apical side of the cell; C–H, progressively more
basal views) through the migrating cell were taken at 0.4-
 
m
 
m in-
tervals using a Bio-Rad MRC 600 confocal laser scanning micro-
scope and MMP-9 (pseudogreen; A, C, E, and G) and vinculin
(pseudored; B, D, F, and H) contents were assessed. MMP-9 was
located slightly behind the leading front of advancing lamellipo-
dia (C, E, and G, arrows), whereas vinculin was more intensely
identified at the forefront of protrusion (D, arrows). Bar, 20 
 
m
 
m. 
The Journal of Cell Biology, Volume 146, 1999 526
 
HBEC; and MMP-9 accumulates close behind this rapidly
remodeled collagen IV at sites with fewer cell–ECM inter-
actions.
We observed that MMP-9 was upregulated only in mi-
grating HBEC and more specifically in those cells lining
the edge of a wound. MMP-9 has been shown to be in-
volved in the migration of many cells (Pluznik et al., 1992;
Leppert et al., 1995; Buisson et al., 1996a; Delclaux et al.,
1996; Okada et al., 1997; McCawley et al., 1998; Uhm et al.,
1998). In most of those studies, MMP-9 involvement in cell
migration was demonstrated by the following observa-
tions: MMP-9 was upregulated and activated during mi-
gration; migration was partially inhibited in the presence
of MMPs, or more specifically, MMP-9 inhibitors (tissue
inhibitor of MMP-1, specific blocking Ab); induction or in-
hibition of cell migration coincided with induction or re-
pression of MMP-9; and cell migration across an ECM
barrier was concomitant with collagen degradation. The in
vitro experimental approaches that we have developed en-
abled us to investigate more extensively the details of
MMP-9 involvement in cell migration. Indeed, the quanti-
fication of cell migration coupled with the MMP-9 local-
ization in migrating cells gives a new insight into the study
of MMP-9 during the migration process. We demonstrated
that, within the cells located close to the edge of the
wound, only the cells that migrated rapidly expressed large
amounts of MMP-9. The MMP-9 location at the edge of
the wound could be explained by the faster migration of
cells at the edge of the wound than those located further
away (Zahm et al., 1997) and the expression of an active
migratory phenotype only by cells at the edge of the
wound, whereas cells further from this front can migrate as
sheets and their migration may be directed by the cells at
the forefront (Zahm et al., 1991).
In agreement with our postulate that the MMP-9 distri-
bution specifically reflects the migration ability of epithe-
lial cells, we also observed that, over a 30-min period, cell
migration at the edge of a wound was heterogeneous but
 
Figure 7
 
. Anti–MMP-9 or anti–collagen IV Ab inhibits HBEC
migration. (A and B) 1 d after injuring primary cultures of
HBEC, cell migration was measured after fluorescent labeling of
cell nuclei, as described in Materials and Methods. Migration
speeds of the cells (
 
n
 
 
 
5 
 
20) located at the edge of the wound were
determined every 20 min (A) or 15 min (B) over a 60-min (A) or
45-min (B) control period. (A) At 60 min, 20 
 
m
 
g/ml of 6-6B anti–
MMP-9 mAb (closed circles) or 20 
 
m
 
g/ml of control mouse IgG
(open circles) was added to the culture medium and the migra-
tion speeds of the same cells were monitored over an additional
60-min period. (B) At 45 min, 30 
 
m
 
g/ml (closed circles) or 15 
 
m
 
g/ml
(closed triangles) of anti–collagen IV Ab or 30 
 
m
 
g/ml of control
IgG (open circles) was added to the culture medium, and the mi-
gration speeds of the same cells were monitored for an additional
45-min period. Each bar represents the mean 
 
6
 
 SD of the migra-
tion speed of 20 cells. Cell migration at each time and in the pres-
ence of Ab was compared (paired t test) to cell migration during
the control period: *P , 0.05, **P , 0.01, ***P , 0.001. (C–E)
FITC–phalloidin labeling of actin in a culture exposed to a con-
trol Ab (C), the anti–MMP-9 6-6B mAb (D), or the anti–collagen
IV Ab (E). In C and D, numerous sites of intense actin labeling
are seen at the tip of cell protrusions (arrowheads). After expo-
sure to the anti–collagen IV Ab, actin labeling at the forefront of
the cell became very faint (E, arrowheads), whereas strongly la-
beled microfilament bundles radiating from focal contacts re-
mained in the central part of the cell. Bar, 40 mm.Legrand et al. MMP-9 in Airway Epithelial Cell Migration 527
paralleled the MMP-9 content of migrating cells, whereas
over a period of several hours, cell migration was uniform.
These observations suggest that HBEC migration is a
step-by-step process in which MMP-9 expression is highly
and rapidly regulated. Induction of MMP-9 expression in
migrating HBEC might reflect a modification of the ECM
onto which the cells are progressing. For example, collage-
nase 1 (MMP-1) is expressed by migrating keratinocytes
that have moved off an intact basement membrane and
are in contact with dermal and provisional matrices (Sa-
arialho-Kere et al., 1993). Recently, Yao et al. (1998)
observed a lower constitutive production of MMP-9 by
HBEC cultured on type IV collagen than on type I and III
collagens, suggesting that type IV collagen is associated
with a homeostatic phenotype and type I and III collagens
with a matrix resorption phenotype. In contrast, our re-
sults indicate that type IV collagen is actively involved in
HBEC migration because collagen IV was produced by
migrating HBEC; collagen IV was specifically amassed at
primordial contacts, the first cell–ECM contacts involved
in cell migration; and the anchorage of cells onto collagen
IV was essential for subsequent cell migration. Another
possible mechanism of regulation of MMP-9 expression in
migrating HBEC is via cell–cell adhesion molecules and
changes in cell shape (Vu and Werb, 1998). We observed
that the disorganization of the actin cytoskeleton altered
MMP-9 distribution in migrating HBEC. Recently, Chin-
tala et al. (1998) reported that actin polymerization was re-
quired for the induction of MMP-9 and subsequent in-
vasive properties of human glioma cells. Thus, actin is
probably a key molecule controlling cell migration, MMP-9
expression, and trafficking in HBEC repairing a wound.
The active involvement of MMP-9 in HBEC migration
led us to examine the question of the sequence of events
occurring during cell migration and how MMP-9 could
participate in it. Cell locomotion is a dynamic interplay of
various processes, such as cell–ECM adhesion, extension
of the leading edge of the cell, and retraction of the trailing
edge. To move along the ECM, cells must first adhere to it,
through cell–ECM contacts, with sufficiently strong links
to allow subsequent spreading of the cell margin. In rap-
idly moving cells, adequate cell–ECM contacts are pro-
vided by highly labile regions of close contact, called pri-
mordial contacts, distributed at the cell front heading in
the direction of migration (Lee et al., 1993; Small et al.,
1996). Primordial contacts are present at the leading edge
of migrating HBEC and they are characterized by a dense
accumulation of actin filaments and the presence of vincu-
lin and type IV collagen. These primordial contacts are
very short-lived structures. Assuming that lamellipodia in
migrating HBEC move at 0.5–1.5 mm/min (Fig. 3) and the
collagen–vinculin band is z2.5-mm wide (Fig. 6), the life
span of primordial contacts should be 1–5 min. The rapid
remodeling of primordial contacts may be attributed to
MMP-9 because of the following: MMP-9 is detected
within and around cell–ECM contacts, most MMP-9 being
identified just behind primordial contacts at sites with
fewer cell–ECM interactions; behind the MMP-9 band in
extending lamellipodia, a migrating cell establishes new
contacts with the ECM through fibronectin-containing fo-
cal contacts; when MMP-9 activation is blocked, cells re-
main fixed on the previously established primordial con-
Figure 8. After exposure to the 6-6B anti–MMP-9 mAb, HBEC
become immobilized, whereas in the presence of an anti–collagen
IV Ab, they spread but do not migrate. 1 d after injuring primary
cultures of HBEC, 20 mg/ml of 6-6B anti–MMP-9 mAb (A–D) or
30 mg/ml of polyclonal anti–collagen IV Ab (E–H) was added for
90 min. A series of phase-contrast images of cells at the edge of
the wound were taken at 8-min intervals. In all images, the lead-
ing edge of the cells at the beginning of the recording (A and E)
is indicated by a thin white line in B–D and F–H, respectively.
Comparison of this line with the subsequent positions of the cells
enables parts of the cells that had spread or retracted during the
8-min period to be localized (arrowheads). In the presence of
the anti–MMP-9 mAb and under the phase-contrast microscope,
the cell border appears dark and thick, whereas in the presence
of the anti–collagen IV Ab, the cell border is more difficult to see
(A and E, arrows). Bar, 70 mm.The Journal of Cell Biology, Volume 146, 1999 528
tacts and no longer move; and confocal microscopy and
zymography analysis of ECM-associated MMP-9 showed
that MMP-9 was subsequently found active on the ECM,
which is consistent with an extracellular action of MMP-9
on the preceding cell–ECM interactions. When studying
the location and activation of gelatinases in endothelial
cells, Partridge et al. (1997) noted that gelatinases colocal-
ized with b1-integrin, thereby indicating the incorporation
of gelatinases into focal contacts.
Those authors suggested that endothelial cells release
MMPs into the extracellular milieu, and then direct and
activate gelatinases at the focal contacts. More recently,
MMP-9 was shown to be accumulated and released at the
tip of pseudopods of endothelial cells invading a collagen
gel (Nguyen et al., 1998). In our study, MMP-9 was not
observed at the leading edge of advancing lamellipodia.
Taken together, these observations suggest that MMP-9
distribution in invasive cells during angiogenesis (three-
dimensional migration), i.e., association of MMP-9 with
cell–ECM contacts, differs from that in repairing migra-
tory cells (two-dimensional migration), i.e., location of
MMP-9 close to cell–ECM contacts. An invasive cell would
first have to digest to some extent its extracellular micro-
environment before moving, whereas a cell migrating along
the ECM would first have to establish contacts with this
substrate, and then remodel these contacts to advance.
Whereas the extending lamellipodia of repairing HBEC
formed primordial contacts via type IV collagen, we ob-
served that in the more central part of a migrating cell,
type IV collagen disappeared from the cell–ECM contacts
and cells are anchored to fibronectin at sites of focal con-
tacts. We previously reported that fibronectin and the cor-
responding a5b1 integrin play an important role in the pro-
cess of airway epithelium wound repair (Hérard et al.,
1996a). These findings suggest that migrating HBEC pro-
duce different ECM molecules to be used for anchorage
and that these distinct molecules play specific roles in the
different cell–ECM contacts.
In conclusion, we hypothesize that wound repair by
HBEC involves the following sequence of migrating events:
anchorage onto type IV collagen via primordial contacts;
MMP-9 trafficking just behind type IV collagen, to rapidly
remodel these primordial contacts through the specific
degradation of type IV collagen; and establishment of
more stable fibronectin-containing contacts in the central
part of the cell, while new primordial contacts with type IV
collagen are made at the forefront.
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Figure 9. Extracellular gelatinase activity during HBEC migra-
tion. (A and B) HBEC were cultured on 3H-gelatin–containing
type I collagen and locally injured at confluency with sodium hy-
droxide. The wound-repair process was followed for 48 h in the
presence of Green’s culture medium either complete (Control)
or without any supplements (DMEM/F12) or in the presence of
35 mM cycloheximide (Cyclohex), of 1 or 5 mM batimastat (Ba-
tim). During the wound-repair process, the wound relative area
(A) and the [3H]radioactivity released in the culture medium (B)
were evaluated in each condition and compared (t test) at each
time to the same parameter in the control experiment: *P , 0.05,
** P, 0.01, *** P, 0.001. Each condition (mean 6 SD) was run
in quintuplicates. (C) 1 d after injuring primary and confluent
cultures of HBEC, derived from four different bronchial samples
(1–4), an aqueous (A) or detergent (D) protein extract from mi-
grating HBEC repairing a wound was prepared and subjected to
gelatin zymography as described in Materials and Methods. The
location of gelatinolytic bands with the appropriate molecular
mass in kilodaltons is reported on the right.Legrand et al. MMP-9 in Airway Epithelial Cell Migration 529
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